NO885231D0 - Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll. - Google Patents

Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll.

Info

Publication number
NO885231D0
NO885231D0 NO885231A NO885231A NO885231D0 NO 885231 D0 NO885231 D0 NO 885231D0 NO 885231 A NO885231 A NO 885231A NO 885231 A NO885231 A NO 885231A NO 885231 D0 NO885231 D0 NO 885231D0
Authority
NO
Norway
Prior art keywords
peptime
immunogens
structures
fertility control
fertility
Prior art date
Application number
NO885231A
Other languages
English (en)
Other versions
NO885231L (no
Inventor
Jean-Michel Bidart
Dominique Bellet
Claude Bohuon
Original Assignee
Lafon Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Pharma filed Critical Lafon Pharma
Publication of NO885231D0 publication Critical patent/NO885231D0/no
Publication of NO885231L publication Critical patent/NO885231L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO88885231A 1987-11-26 1988-11-24 Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll. NO885231L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716420A FR2623715B1 (fr) 1987-11-26 1987-11-26 Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite

Publications (2)

Publication Number Publication Date
NO885231D0 true NO885231D0 (no) 1988-11-24
NO885231L NO885231L (no) 1989-05-29

Family

ID=9357207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885231A NO885231L (no) 1987-11-26 1988-11-24 Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll.

Country Status (22)

Country Link
US (1) US5496551A (no)
EP (1) EP0323769B1 (no)
JP (1) JP2509312B2 (no)
KR (1) KR890008171A (no)
CN (1) CN1034208A (no)
AP (1) AP71A (no)
AT (1) ATE102957T1 (no)
AU (1) AU617716B2 (no)
DE (1) DE3888509T2 (no)
DK (1) DK660888A (no)
EG (1) EG18596A (no)
ES (1) ES2052762T3 (no)
FR (1) FR2623715B1 (no)
IE (1) IE883545L (no)
IL (1) IL88381A (no)
MA (1) MA21448A1 (no)
NO (1) NO885231L (no)
NZ (1) NZ227073A (no)
OA (1) OA08971A (no)
PT (1) PT89053B (no)
TN (1) TNSN88129A1 (no)
ZA (1) ZA888733B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9001709A (nl) * 1990-07-27 1992-02-17 Stichting Centr Diergeneeskund Peptiden en farmaceutische preparaten met een glycoprotene hormoon agonistische of antagonistische werking.
FR2710845B1 (fr) * 1993-10-08 1996-03-29 Lafon Labor Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
FR2702494B1 (fr) * 1993-03-11 1995-06-09 Lafon Labor Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
WO1994020859A1 (fr) * 1993-03-11 1994-09-15 Laboratoire L. Lafon TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
WO2000004913A1 (en) * 1998-07-23 2000-02-03 Eli Lilly And Company Fsh and fsh variant formulations, products and methods
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
DK159276C (da) * 1980-03-31 1991-02-18 Takeda Chemical Industries Ltd Fremgangsmaade til isolering af specifikke antistoffer og enzym-immunbestemmelsesmetode med anvendelse af det isolerede antistof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0142387A1 (en) * 1983-08-26 1985-05-22 Anda Biologicals Process for the preparation of vaccines specific for LH and HCG and process for their detection
EP0224574A4 (en) * 1985-06-04 1988-04-26 Biotech Res Partners Ltd SELF-ANTIGEN VACCINES.
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides

Also Published As

Publication number Publication date
AU2596888A (en) 1989-06-01
US5496551A (en) 1996-03-05
FR2623715A1 (fr) 1989-06-02
IE883545L (en) 1989-05-26
TNSN88129A1 (fr) 1990-07-10
FR2623715B1 (fr) 1990-12-21
OA08971A (fr) 1990-11-30
PT89053A (pt) 1988-12-01
DK660888A (da) 1989-05-27
ES2052762T3 (es) 1994-07-16
EP0323769B1 (fr) 1994-03-16
IL88381A0 (en) 1989-06-30
IL88381A (en) 1993-03-15
AU617716B2 (en) 1991-12-05
MA21448A1 (fr) 1989-07-01
PT89053B (pt) 1993-04-30
ZA888733B (en) 1990-08-29
DE3888509D1 (de) 1994-04-21
ATE102957T1 (de) 1994-04-15
DE3888509T2 (de) 1994-10-06
JPH01301696A (ja) 1989-12-05
JP2509312B2 (ja) 1996-06-19
AP71A (en) 1990-02-24
NZ227073A (en) 1990-06-26
EG18596A (en) 1993-07-30
AP8800110A0 (en) 1989-01-31
KR890008171A (ko) 1989-07-10
NO885231L (no) 1989-05-29
CN1034208A (zh) 1989-07-26
EP0323769A1 (fr) 1989-07-12
DK660888D0 (da) 1988-11-25

Similar Documents

Publication Publication Date Title
NO823657L (no) N-aminoalkyl-jodtyroninderivater, jodtyroninimmunogener og antilegemer.
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
NO861445L (no) Naske-sikker kapsel, og fremgangsmaate og anordning for fremstilling av samme.
FI883633A0 (fi) Digitalt, interaktivt telekommunikationssystem.
FI881077A (fi) Skyddsglas, saerskilt foer tandlaekare.
FI882731A0 (fi) Skiljevaegg, saerskilt hoern- eller rundduschvaegg.
FI880945A (fi) Perforerad, ljudabsorberande skiva.
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
DK210483D0 (da) Pyrogallolderivater, deres anvendelse og fremgangsmade til fremstilling deraf
FI885747A (fi) Stabila, flytande tvaettmedelsaemnen.
NO862976D0 (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling og deres anvendelse.
NO885231D0 (no) Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll.
FI880454A (fi) Laosanordning, saerskilt foer en lucka till en dammsugare.
FI883395A (fi) Polyarylalkaners oligomersammansaettningar, foerfarande foer deras framstaellning.
FI880683A0 (fi) Skodon, isynnerhet sandaler.
FI880989A0 (fi) Skaop, saerskilt badrumsskaop.
FI882352A (fi) En reaktionsring inrymmande taetande innerroer, speciellt foer en tillslutningsanordning.
FI883220A (fi) Kranarmsystem, speciellt foer mobila kranar.
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.
DE3875267D1 (de) Heptaenantibiotikum, v-28-3m.
FI872949A (fi) Underlagsmatta foer golvbelaeggning, saerskilt foer mosaikparkett.
NO822200L (no) 24-cyklopropylcholen-3beta,22-dioler og fremgangsmaate for deres fremstilling.
NO885571D0 (no) Porfyriner, deres syntese og anvendelse.
NO872282D0 (no) Framgangsmaate for traaling.
FI884717A0 (fi) Spole, saerskilt sytraodsspole foer minutfoersaeljning.